S100A4 is a calcium-binding protein that plays critical roles in cancer progression, metastasis, and cellular signaling. The protein promotes tumor cell invasion and metastasis through multiple mechanisms, including activation of STAT3 signaling pathways 1. S100A4 can be secreted in exosomes from highly metastatic cancer cells, where it enhances metastatic potential by inducing osteopontin expression via STAT3 phosphorylation 1. In tumor-associated macrophages, S100A4 controls protumor polarization by regulating PPAR-γ-dependent fatty acid oxidation, facilitating cancer progression 2. The protein also modulates the tumor microenvironment, with S100A4-positive cancer-associated fibroblasts changing composition during breast cancer progression and correlating with disease outcome 3. Beyond cancer, S100A4 contributes to fibrotic diseases, where anti-S100A4 monoclonal antibody treatment effectively reduces skin fibrosis by targeting inflammatory and fibrotic pathways 4. S100A4 is expressed in various cell types including mast cells, where it regulates cell growth, apoptosis, and matrix metalloproteinase production 5, and in dental odontoblasts as a cellular marker 6. The protein's diverse functions make it a potential therapeutic target and prognostic marker across multiple diseases.